T STAMP INC-CLASS A (IDAI)

US8730484099 - Common Stock

0.245  +0.03 (+15.73%)

After market: 0.2302 -0.01 (-6.04%)

Fundamental Rating

2

Overall IDAI gets a fundamental rating of 2 out of 10. We evaluated IDAI against 281 industry peers in the Software industry. IDAI has a bad profitability rating. Also its financial health evaluation is rather negative. IDAI shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

IDAI had negative earnings in the past year.
IDAI had a negative operating cash flow in the past year.
IDAI had negative earnings in each of the past 5 years.
IDAI had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of IDAI (-157.92%) is worse than 95.02% of its industry peers.
With a Return On Equity value of -1092.96%, IDAI is not doing good in the industry: 87.54% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -157.92%
ROE -1092.96%
ROIC N/A
ROA(3y)-130%
ROA(5y)-133.18%
ROE(3y)-1005.93%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

IDAI has a Gross Margin of 78.05%. This is in the better half of the industry: IDAI outperforms 75.09% of its industry peers.
IDAI's Gross Margin has improved in the last couple of years.
IDAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 78.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y23.31%
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

IDAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for IDAI has been increased compared to 1 year ago.
Compared to 1 year ago, IDAI has an improved debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -19.27, we must say that IDAI is in the distress zone and has some risk of bankruptcy.
IDAI's Altman-Z score of -19.27 is on the low side compared to the rest of the industry. IDAI is outperformed by 94.31% of its industry peers.
A Debt/Equity ratio of 1.27 is on the high side and indicates that IDAI has dependencies on debt financing.
IDAI's Debt to Equity ratio of 1.27 is on the low side compared to the rest of the industry. IDAI is outperformed by 77.58% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z -19.27
ROIC/WACCN/A
WACC9.18%

2.3 Liquidity

IDAI has a Current Ratio of 0.64. This is a bad value and indicates that IDAI is not financially healthy enough and could expect problems in meeting its short term obligations.
IDAI has a Current ratio of 0.64. This is amonst the worse of the industry: IDAI underperforms 89.32% of its industry peers.
A Quick Ratio of 0.64 indicates that IDAI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.64, IDAI is doing worse than 89.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.64
Quick Ratio 0.64

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.76% over the past year.
Looking at the last year, IDAI shows a very strong growth in Revenue. The Revenue has grown by 69.75%.
The Revenue has been growing by 19.83% on average over the past years. This is quite good.
EPS 1Y (TTM)63.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.38%
Revenue 1Y (TTM)69.75%
Revenue growth 3Y19.83%
Revenue growth 5YN/A
Sales Q2Q%8.78%

3.2 Future

The Earnings Per Share is expected to grow by 27.27% on average over the next years. This is a very strong growth
Based on estimates for the next years, IDAI will show a very strong growth in Revenue. The Revenue will grow by 24.57% on average per year.
EPS Next Y66.29%
EPS Next 2Y27.27%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-50.75%
Revenue Next 2Y24.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

IDAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year IDAI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as IDAI's earnings are expected to grow with 27.27% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.27%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

IDAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

T STAMP INC-CLASS A

NASDAQ:IDAI (11/4/2024, 8:15:38 PM)

After market: 0.2302 -0.01 (-6.04%)

0.245

+0.03 (+15.73%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap4.61M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -157.92%
ROE -1092.96%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 78.05%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.64
Quick Ratio 0.64
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)63.76%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y66.29%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)69.75%
Revenue growth 3Y19.83%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y